{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-132583","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2021-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.378190+00:00","generated_at":"2026-06-28T15:11:29.083969+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Corvus enters $40M ATM equity offering with Jefferies LLC","bullets":["Sales agreement for up to $40M in common stock, Jefferies as sales agent.","Jefferies receives up to 3% commission on gross proceeds from sales.","Sales may occur through Nasdaq, block trades, or privately negotiated transactions.","Company may suspend or terminate the agreement at any time; no obligation to sell shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-132583","json":"https://secwatch.observer/filing/0001104659-21-132583.json","markdown":"https://secwatch.observer/filing/0001104659-21-132583.md","text":"https://secwatch.observer/filing/0001104659-21-132583.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000110465921132583/0001104659-21-132583-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000110465921132583/tm2131487d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T15:11:29.083969+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}